Command Palette

Search for a command to run...

Clinical Trials · NCT07055607

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

Enrolling By InvitationN/ASemaglutide (Investigational)
Phase
N/A
Recruitment status
Enrolling By Invitation
Sponsor
Novo Nordisk A/S
Enrollment
1,250
Start date
May 2025
Locations
30 sites, 3 countries
Primary endpoint
Absolute change in body weight (kilograms [kg])
View Semaglutide compound reference